Showing results (251-260 of 283) with videos related to

Sort By:
Pageof 29
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 30, 2019
Alpha-1 Antitrypsin-Expressing Mesenchymal Stromal Cells Confer a Long-Term Survival Benefit in a Mouse Model of Lethal GvHDSabine Geiger, Emrah I Ozay, Ulf Geumann, et al.
Bioorganic & Medicinal Chemistry|February 13, 2010
Synthesis, metabolism and in vitro cytotoxicity studies on novel lavendamycin antitumor agentsWen Cai, Mary Hassani, Rajesh Karki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 25, 2022
External Validation of the 2003 Leibovich Prognostic Score in Patients Randomly Assigned to SORCE, an International Phase III Trial of Adjuvant Sorafenib in Renal Cell CancerBhavna Oza, Tim Eisen, Eleni Frangou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2020
Adjuvant Sorafenib for Renal Cell Carcinoma at Intermediate or High Risk of Relapse: Results From the SORCE Randomized Phase III Intergroup TrialTim Eisen, Eleni Frangou, Bhavna Oza, et al.
Annals of the Rheumatic Diseases|January 16, 2016
Defining active sacroiliitis on MRI for classification of axial spondyloarthritis: update by the ASAS MRI working groupRobert G W Lambert, Pauline A C Bakker, Désirée van der Heijde, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2018
Molecular Markers Increase Precision of the European Association of Urology Non-Muscle-Invasive Bladder Cancer Progression Risk GroupsKim E M van Kessel, Kirstin A van der Keur, Lars Dyrskjøt, et al.
Nature Genetics|January 3, 2025
Comprehensive genomic characterization of early-stage bladder cancerFrederik Prip, Philippe Lamy, Sia Viborg Lindskrog, et al.
Pageof 29